Extra Time to Comment on Pill Strength Testing Waivers
Published Date: 9/9/2025
Notice
Summary
The FDA is giving drug makers more time to share their thoughts on new rules about testing different strengths of certain pills without extra studies. This helps companies save time and money when proving their medicines work the same. If you’re in the drug business, now’s your chance to speak up before the deadline!
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in